Cadila Healthcare enters into agreement with Phibro

commodity tips


Get FREE TRIALS ( INDIAN STOCK MARKET ) CALL ON 9644405056 or you can click here >>


Leading pharma company, Zydus Cadila has said that it has entered into a long-term arrangement with Phibro Animal Health Corporation to license Phibro’s innovative poultry vaccine technologies and know-how to a new vaccine manufacturing facility to be built by Zydus Cadila to serve the fast growing poultry market in India.


Commenting on the issue, Jack Bendheim, Chairman, President and Chief Executive Officer of Phibro said, “We are proud of the more than 20-year partnership with Zydus Cadila serving the Indian animal health market and we view this as an exciting next step in our relationship.” 


Speaking on the development Mr. Pankaj R. Patel, Chairman and Managing Director, Zydus group said, “Our endeavor has always been to enable access to innovative therapies across geographies and this agreement with Phibro will help bring innovations to the poultry market in India.